GH Research GHRS
NASDAQ GHRS
$28.23 +0.31 (+1.11%)
As of: Sep 4, 2026 · 3:59 PM EDT

GH Research (GHRS) Short-term Investments (2020 - 2026)

GH Research (GHRS) posted quarterly Short-term Investments of $12.6 million for Q1 2025, down 75.54% year-over-year from $51.3 million in Q1 2024, and down 35.22% quarter-over-quarter from $19.4 million in Q4 2024.

Analysis

GH Research (GHRS) Short-term Investments (2020 - 2026) Analysis & Trends

GH Research's Short-term Investments history runs 5 years deep, the most recent figure standing at $12.6 million for Q1 2025.

  • In Q1 2025, Short-term Investments fell 75.54% year-over-year to $12.6 million; the TTM figure through Mar 2025 stood at $12.6 million (down 75.54% YoY), while the FY2024 annual figure was $19.4 million, down 65.14% from the prior year.
  • Short-term Investments for Q1 2025 stood at $12.6 million, down from $19.4 million in the prior quarter.
  • The five-year high for Short-term Investments was $55.6 million in Q4 2023, with the low at $10000.0 in Q4 2021.
  • The 4-year median for Short-term Investments is $46.7 million (2024), against an average of $37.8 million.
  • The sharpest annual moves came in 2021 and 2025: Short-term Investments jumped 100.0% in 2021, then sank 75.54% in 2025.
  • GH Research's Short-term Investments stood at $10000.0 in 2021, then jumped by 556050.0% to $55.6 million in 2023, then plunged by 65.14% to $19.4 million in 2024, then plunged by 35.22% to $12.6 million in 2025.
  • Business Quant data shows GHRS's Short-term Investments at $12.6 million in Q1 2025, $19.4 million in Q4 2024, and $32.5 million in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 GH Research 1.72 Bn 1.36 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.60 Mn
Mar 31, 2026 24.67 Mn
Dec 31, 2025 34.46 Mn
Mar 31, 2025 12.56 Mn
Dec 31, 2024 19.39 Mn
Sep 30, 2024 32.52 Mn
Jun 30, 2024 41.97 Mn
Mar 31, 2024 51.35 Mn
Dec 31, 2023 -54.00 Mn
Sep 30, 2023 55.49 Mn
Jun 30, 2023 54.73 Mn
Mar 31, 2023 54.06 Mn
Dec 31, 2020 5,000.00